Basel Medical Group Ltd Ordinary Shares (BMGL) vs Lunai Bioworks Inc. (LNAI)

A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Lunai Bioworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Basel Medical Group Ltd Ordinary Shares logo
BMGL
Basel Medical Group Ltd Ordinary Shares
$5M
$3.33HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Lunai Bioworks Inc. logo
LNAI
Lunai Bioworks Inc.
$5M
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BMGL vs LNAI

growth of $100 · dividends reinvested · last 1y
BMGL -86.8% (-86.8%/yr)LNAI -93.8% (-93.8%/yr)BMGL compounded faster over this window
020406080100Start $1002026$13$6
BMGL LNAI

BMGL vs LNAI: by the numbers

  • •BMGL is the larger company ($5M vs $5M market cap).
  • •Both run net losses; BMGL's is the smaller (-106.78% vs -612568.11% net margin).

Metrics side by side

Valuation

MetricBMGLLNAI
P/S ratioN/A244.64
P/B ratio1.07N/A

Profitability

MetricBMGLLNAI
Gross margin77.68%0.00%
Operating margin-19.28%0.00%
Net margin-106.78%-612568.11%
ROE-248.66%N/A
ROIC-35.07%N/A

Go deeper

Full BMGL analysisFull LNAI analysisInteractive comparison tool

Dig into the metrics

Basel Medical Group Ltd Ordinary Shares ROELunai Bioworks ROEBasel Medical Group Ltd Ordinary Shares operating marginLunai Bioworks operating marginBasel Medical Group Ltd Ordinary Shares revenue growthLunai Bioworks revenue growthBasel Medical Group Ltd Ordinary Shares free cash flowLunai Bioworks free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.